Frontiers in Immunology (Aug 2018)

Bradyrhizobium Lipid A: Immunological Properties and Molecular Basis of Its Binding to the Myeloid Differentiation Protein-2/Toll-Like Receptor 4 Complex

  • Luigi Lembo-Fazio,
  • Jean-Marc Billod,
  • Flaviana Di Lorenzo,
  • Ida Paciello,
  • Mateusz Pallach,
  • Sara Vaz-Francisco,
  • Aurora Holgado,
  • Aurora Holgado,
  • Rudi Beyaert,
  • Rudi Beyaert,
  • Manuel Fresno,
  • Atsushi Shimoyama,
  • Rosa Lanzetta,
  • Koichi Fukase,
  • Djamel Gully,
  • Eric Giraud,
  • Sonsoles Martín-Santamaría,
  • Maria-Lina Bernardini,
  • Maria-Lina Bernardini,
  • Alba Silipo

DOI
https://doi.org/10.3389/fimmu.2018.01888
Journal volume & issue
Vol. 9

Abstract

Read online

Lipopolysaccharides (LPS) are potent activator of the innate immune response through the binding to the myeloid differentiation protein-2 (MD-2)/toll-like receptor 4 (TLR4) receptor complexes. Although a variety of LPSs have been characterized so far, a detailed molecular description of the structure–activity relationship of the lipid A part has yet to be clarified. Photosynthetic Bradyrhizobium strains, symbiont of Aeschynomene legumes, express distinctive LPSs bearing very long-chain fatty acids with a hopanoid moiety covalently linked to the lipid A region. Here, we investigated the immunological properties of LPSs isolated from Bradyrhizobium strains on both murine and human immune systems. We found that they exhibit a weak agonistic activity and, more interestingly, a potent inhibitory effect on MD-2/TLR4 activation exerted by toxic enterobacterial LPSs. By applying computational modeling techniques, we also furnished a plausible explanation for the Bradyrhizobium LPS inhibitory activity at atomic level, revealing that its uncommon lipid A chemical features could impair the proper formation of the receptorial complex, and/or has a destabilizing effect on the pre-assembled complex itself.

Keywords